TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 42 filers reported holding TARSUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $364,710 | +54.3% | 20,552 | +57.1% | 0.00% | – |
| Q2 2023 | $236,374 | +156.0% | 13,081 | +78.1% | 0.00% | – |
| Q1 2023 | $92,327 | -8.8% | 7,345 | +6.4% | 0.00% | – |
| Q4 2022 | $101,198 | +146.8% | 6,903 | +182.9% | 0.00% | – |
| Q3 2022 | $41,000 | +86.4% | 2,440 | +59.4% | 0.00% | – |
| Q2 2022 | $22,000 | +46.7% | 1,531 | +76.4% | 0.00% | – |
| Q1 2022 | $15,000 | -21.1% | 868 | +6.1% | 0.00% | – |
| Q4 2021 | $19,000 | +5.6% | 818 | 0.0% | 0.00% | – |
| Q3 2021 | $18,000 | -25.0% | 818 | 0.0% | 0.00% | – |
| Q2 2021 | $24,000 | +14.3% | 818 | +28.0% | 0.00% | – |
| Q1 2021 | $21,000 | -22.2% | 639 | 0.0% | 0.00% | – |
| Q4 2020 | $27,000 | – | 639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,140,586 | $38,038,213 | 5.37% |
| Vivo Capital, LLC | 2,262,200 | $40,199,294 | 4.40% |
| TCG Crossover Management, LLC | 1,142,857 | $20,308,569 | 2.99% |
| Cormorant Asset Management, LP | 2,621,422 | $46,582,669 | 2.72% |
| Ghost Tree Capital, LLC | 400,000 | $7,108,000 | 2.34% |
| COWEN AND COMPANY, LLC | 1,796,773 | $31,928,656 | 2.23% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $31,764,355 | 2.11% |
| TFG Asset Management GP Ltd | 615,000 | $10,928,550 | 1.99% |
| Sands Capital Ventures, LLC | 260,000 | $4,620,200 | 1.37% |
| Ikarian Capital, LLC | 518,519 | $9,214,083 | 1.11% |